SCHEDULE 13G/A: BlackRock Amends Stake in Pulmonx Corp, Disclosing 6.8% Beneficial Ownership

BlackRock, Inc. has filed an Amendment No. 3 to Schedule 13G, revealing a 6.8% beneficial ownership stake in Pulmonx Corp's common stock as of March 31, 2025.

Summary

• BlackRock, Inc. reported beneficial ownership of 2,694,998 shares of Pulmonx Corp's common stock.
• This aggregate amount represents 6.8% of the class of securities outstanding.
• BlackRock holds sole voting power over 2,674,965 shares and sole dispositive power over 2,694,998 shares.
• No shared voting or dispositive power was reported.
• The securities were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing the control of Pulmonx Corp.
• Several BlackRock subsidiaries, including BlackRock Advisors, LLC and BlackRock Financial Management, Inc., are identified as entities that beneficially own shares, with at least one owning 5% or greater of the outstanding shares.

Sentiment

Score: 6

Explanation: The sentiment is moderately positive due to a significant institutional investor maintaining a substantial stake, implying confidence, though the document itself is purely factual and regulatory.

Positives

• BlackRock, a major institutional investor, holding a significant 6.8% stake in Pulmonx Corp may signal institutional confidence in the company's long-term prospects.
• The filing explicitly states that the shares were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control, indicating a passive, investment-oriented holding.

Negatives

• The Schedule 13G filing itself does not contain information regarding negative aspects of Pulmonx Corp's financial performance or operational challenges.

Risks

• The document does not detail specific risks related to Pulmonx Corp's business operations or financial health. It primarily focuses on BlackRock's ownership disclosure.

Future Outlook

NA

Industry Context

This filing is a standard disclosure of institutional ownership and does not provide specific industry context or analysis related to Pulmonx Corp's market position or trends.

Stakeholder Impact

• Shareholders: The disclosure of a significant stake by a major institutional investor like BlackRock may be viewed positively by other shareholders, potentially signaling stability and long-term interest in Pulmonx Corp.

Next Steps

• Pulmonx Corp will continue its regular SEC reporting as required.
• BlackRock, Inc. will continue to monitor its investment and file future amendments to Schedule 13G if its beneficial ownership percentage changes significantly (e.g., by 1% or more).

Key Dates

Keywords

BlackRock, Pulmonx Corp, Schedule 13G, Beneficial Ownership, Common Stock, Institutional Investor, SEC Filing, Ownership Disclosure